# Preventive Application of GnRH Antagonist on Early OHSS

> **NCT03188471** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 175 (estimated)

## Conditions studied

- Ovarian Hyperstimulation Syndrome
- GnRH Antagonist
- Aspirin
- Vascular Endothelial Growth Factor
- Pigment Epithelium Derived Factor

## Interventions

- **DRUG:** GnRH antagonist
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT03188471
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-03
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2017-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188471, "Preventive Application of GnRH Antagonist on Early OHSS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03188471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*